Proguanil is an antimalarial medication and a prodrug that is converted into its active metabolite, cycloguanil, which inhibits dihydrofolate reductase to disrupt parasite folate synthesis. Often administered… Read more






















Proguanil is an antimalarial medication and a prodrug that is converted into its active metabolite, cycloguanil, which inhibits dihydrofolate reductase to disrupt parasite folate synthesis. Often administered alongside chloroquine for malaria treatment and prophylaxis against Plasmodium falciparum, it remains a critical agent in clinical settings. This category encompasses a comprehensive collection of high-quality reference standards for Proguanil, including pharmacopeial and non-pharmacopeial impurities, metabolite standards, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials to facilitate precise impurity profiling, method validation, and rigorous quality control during the production and analysis of the active pharmaceutical ingredient. By providing these essential analytical tools, the catalogue supports the development of reliable assays required to ensure the purity and regulatory compliance of drug substances throughout the manufacturing lifecycle.